UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000028249 |
|---|---|
| Receipt number | R000032327 |
| Scientific Title | Efficacy and safety of ONO-4538 for chemo-refractory germ cell tumors: an open-label, multicentre, phase 2 trial |
| Date of disclosure of the study information | 2017/07/18 |
| Last modified on | 2023/06/02 16:58:27 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/07/14 21:22:31 | ||
| 2 | Update | 2017/08/23 16:08:00 | Institutions |
|
| 3 | Update | 2017/09/27 07:56:39 | Institutions |
|
| 4 | Update | 2017/10/27 20:45:34 | Institutions |
|
| 5 | Update | 2017/11/24 12:09:09 | Institutions |
|
| 6 | Update | 2018/12/27 19:22:38 | Recruitment status |
|
| 7 | Update | 2019/02/13 18:40:27 | UMIN ID1 |
|
| 8 | Update | 2020/01/15 17:46:07 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of person sending information Name of person sending information Organization Organization Address Address Tel |
|
| 9 | Update | 2021/07/19 07:52:28 | Number of participants that the trial has enrolled |
|
| 10 | Update | 2021/07/19 08:02:51 | Date of IRB Last follow-up date |
|
| 11 | Update | 2021/07/19 08:09:37 | Recruitment status |
|
| 12 | Update | 2023/06/02 16:58:27 | URL releasing protocol Publication of results URL related to results and publications Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
